|
1
|
Bray F, Sankila R, Ferlay J and Parkin DM:
Estimates of cancer incidence and mortality in Europe in 1995. Eur
J Cancer. 38:99–166. 2002. View Article : Google Scholar
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu JP, Chen SM, Cong YS, Nicholls C, Zhou
SF, Tao ZZ and Li H: Regulation of telomerase activity by
apparently opposing elements. Ageing Res Rev. 9:245–256. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shay JW and Wright WE: Hallmarks of
telomeres in ageing research. J Pathol. 211:114–123. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kapanadze B, Morris E, Smith E and
Trojanowska M: Establishment and characterization of scleroderma
fibroblast clonal cell lines by introduction of the hTERT gene. J
Cell Mol Med. 14:1156–1165. 2010.
|
|
6
|
Wieser M, Stadler G, Jennings P, Streubel
B, Pfaller W, Ambros P, Riedl C, Katinger H, Grillari J and
Grillari-Voglauer R: hTERT alone immortalizes epithelial cells of
renal proximal tubules without changing their functional
characteristics. Am J Physiol Renal Physiol. 295:F1365–F1375. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stewart SA, Hahn WC, O’Connor BF, et al:
Telomerase contributes to tumorigenesis by a telomere
length-independent mechanism. Proc Natl Acad Sci USA.
99:12606–12611. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smith LL, Coller HA and Roberts JM:
Telomerase modulates expression of growth-controlling genes and
enhances cell proliferation. Nat Cell Biol. 5:474–479. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang C, Przyborski S, Cooke MJ, Zhang X,
Stewart R, Anyfantis G, Atkinson SP, Saretzki G, Armstrong L and
Lako M: A key role for telomerase reverse transcriptase unit in
modulating human embryonic stem cell proliferation, cell cycle
dynamics, and in vitro differentiation. Stem Cells. 26:850–863.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee J, Sung YH, Cheong C, Choi YS, Jeon
HK, Sun W, Hahn WC, Ishikawa F and Lee HW: TERT promotes cellular
and organismal survival independently of telomerase activity.
Oncogene. 27:3754–3760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bertorelle R, Briarava M, Rampazzo E, et
al: Telomerase is an independent prognostic marker of overall
survival in patients with colorectal cancer. Br J Cancer.
108:278–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eid MM, Helmy NA, Omar IM, Mohamed AA, El
Sewefy D, Fadel IM and Helal RA: Clinical significance of
telomerase genes (hTERC and hTERT) amplification in patients with
acute myeloid leukemia. Gulf J Oncol. 1:51–60. 2013.
|
|
13
|
Lötsch D, Ghanim B, Laaber M, Wurm G, Weis
S, Lenz S, Webersinke G, Pichler J, Berger W and Spiegl-Kreinecker
S: Prognostic significance of telomerase-associated parameters in
glioblastoma: Effect of patient age. Neurooncol. 15:423–432.
2013.
|
|
14
|
Nakashima A, Murakami Y, Uemura K,
Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Oda M, Sueda T and
Hiyama E: Usefulness of human telomerase reverse transcriptase in
pancreatic juice as a biomarker of pancreatic malignancy. Pancreas.
38:527–533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsuji T, Ibaragi S and Hu GF:
Epithelial-mesenchymal transition and cell cooperativity in
metastasis. Cancer Res. 69:7135–7139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, Li Q, Li K, et al: Telomerase
reverse transcriptase promotes epithelial-mesenchymal transition
and stem cell-like traits in cancer cells. Oncogene. 32:4203–4213.
2013. View Article : Google Scholar
|
|
17
|
Gröger S, Michel J and Meyle J:
Establishment and characterization of immortalized human gingival
keratinocyte cell lines. J Periodontal Res. 43:604–614. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rheinwald JG, Hahn WC, Ramsey MR, Wu JY,
Guo Z, Tsao H, De Luca M, Catricala C and O’Toole KM: A two-stage,
p16 (INK4A)- and p53-dependent keratinocyte senescence mechanism
that limits replicative potential independent of telomere status.
Mol Cell Biol. 22:5157–5172. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dissanayake SK, Wade M, Johnson CE, et al:
The Wnt5A/protein kinase C pathway mediates motility in melanoma
cells via the inhibition of metastasis suppressors and initiation
of an epithelial to mesenchymal transition. J Biol Chem.
282:17259–17271. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park JI, Venteicher AS, Hong JY, et al:
Telomerase modulates Wnt signalling by association with target gene
chromatin. Nature. 460:66–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prieur A and Peeper DS: Cellular
senescence in vivo: A barrier to tumorigenesis. Curr Opin Cell
Biol. 20:150–155. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pelosi G, Schianchi E, Dell’orto P,
Veronesi G, Spaggiari L, Pasini F, Sozzi G, Brambilla E, Griso C
and Viale G: Detecting cell-free circulating hTERT mRNA in the
plasma may identify a subset of nonsmall cell lung cancer patients.
Virchows Arch. 448:7–15. 2006. View Article : Google Scholar
|
|
25
|
Gigek CO, Leal MF, Silva PNO, Lisboa LC,
Lima EM, Calcagno DQ, Assumpção PP, Burbano RR and Smith MA: hTERT
methylation and expression in gastric cancer. Biomarkers.
14:630–636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saini N, Srinivasan R, Chawla Y, Sharma S,
Chakraborti A and Rajwanshi A: Telomerase activity, telomere length
and human telomerase reverse transcriptase expression in
hepatocellular carcinoma is independent of hepatitis virus status.
Liver Int. 29:1162–1170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Divella R, Tommasi S, Lacalamita R, et al:
Circulating hTERT DNA in early breast cancer. Anticancer Res.
29:2845–2849. 2009.PubMed/NCBI
|
|
28
|
Capkova L, Kalinova M, Krskova L, Kodetova
D, Petrik F, Trefny M, Musil J and Kodet R: Loss of heterozygosity
and human telomerase reverse transcriptase (hTERT) expression in
bronchial mucosa of heavy smokers. Cancer. 109:2299–2307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pucciarelli S, Rampazzo E, Briarava M, et
al: Telomere-specific reverse transcriptase (hTERT) and cell-free
RNA in plasma as predictors of pathologic tumor response in rectal
cancer patients receiving neoadjuvant chemoradiotherapy. Ann Surg
Oncol. 19:3089–3096. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sasaki T, Kuniyasu H, Luo Y, Kitayoshi M,
Tanabe E, Kato D, Shinya S, Fujii K, Ohmori H and Yamashita Y: AKT
activation and telomerase reverse transcriptase expression are
concurrently associated with prognosis of gastric cancer.
Pathobiology. 81:36–41. 2014. View Article : Google Scholar
|
|
31
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: Acquisition of
epithelial-mesenchymal transition and cancer stem cell phenotypes
is associated with activation of the PI3K/Akt/mTOR pathway in
prostate cancer radioresistance. Cell Death Dis. 4:e8752013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li NY, Weber CE, Wai PY, Cuevas BD, Zhang
J, Kuo PC and Mi Z: An MAPK-dependent pathway induces
epithelial-mesenchymal transition via Twist activation in human
breast cancer cell lines. Surgery. 154:404–410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kypta RM and Waxman J: Wnt/beta-catenin
signalling in prostate cancer. Nat Rev Urol. 9:418–428. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kahlert UD, Maciaczyk D, Doostkam S, et
al: Activation of canonical WNT/β-catenin signaling enhances in
vitro motility of glioblastoma cells by activation of ZEB1 and
other activators of epithelial-to-mesenchymal transition. Cancer
Lett. 325:42–53. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bertrand FE, McCubrey JA, Angus CW, Nutter
JM and Sigounas G: NOTCH and PTEN in prostate cancer. Adv Biol
Regul. 56:51–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cichon MA and Radisky DC: ROS-induced
epithelial-mesenchymal transition in mammary epithelial cells is
mediated by NF-κB-dependent activation of Snail. Oncotarget.
5:2827–2838. 2014.PubMed/NCBI
|
|
37
|
Hoffmeyer K, Raggioli A, Rudloff S, Anton
R, Hierholzer A, Del Valle I, Hein K, Vogt R and Kemler R:
Wnt/β-catenin signaling regulates telomerase in stem cells and
cancer cells. Science. 336:1549–1554. 2012. View Article : Google Scholar : PubMed/NCBI
|
